Annual report [Section 13 and 15(d), not S-K Item 405]

Document and Entity Information

v3.26.1
Document and Entity Information - USD ($)
 12 Months Ended
Dec. 31, 2025
Mar. 10, 2026
Jun. 30, 2025
Document and Entity Information [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Document Transition Report false    
Securities Act File Number 001-39811    
Entity Registrant Name DOGWOOD THERAPEUTICS, INC.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 85-4314201    
Entity Address, Address Line One 44 Milton Avenue    
Entity Address, City or Town Alpharetta    
Entity Address, State or Province GA    
Entity Address, Postal Zip Code 30009    
City Area Code 866    
Local Phone Number 620-8655    
Title of 12(b) Security Common Stock, $0.0001 Par Value per Share    
Trading Symbol DWTX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 8,092,720
Entity Common Stock, Shares Outstanding   33,401,553  
Entity Central Index Key 0001818844    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag false    
Auditor Name Forvis Mazars, LLP    
Auditor Firm ID 686    
Auditor Location Atlanta, Georgia    
Documents Incorporated by Reference [Text Block]

Part III incorporates certain information by reference from the definitive proxy statement to be filed by the registrant in connection with the 2026 Annual Meeting of Stockholders (the "Proxy Statement") with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the year ended December 31, 2025, provided that if such Proxy Statement is not filed within such period, such information will be included in an amendment to this Annual Report on Form 10-K to be filed within such 120-day period.